Pharming Group to report first quarter 2025 financial results on May 8

Rhea-AI Summary

Pharming Group (Euronext: PHARM/Nasdaq: PHAR) has announced it will release its preliminary unaudited first quarter 2025 financial results on Thursday, May 8, 2025. The results will cover the period ended March 31, 2025.

The company will host an analyst and investor presentation at 13:30 CEST/07:30 EDT on the same day. Questions will only be taken from dial-in attendees who register in advance through the provided conference call link.

Leiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2025 financial results, for the period ended March 31, on Thursday, May 8, 2025.

Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2025.

To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.

Conference call registration:
Please note, the Company will only take questions from dial-in attendees.

https://register-conf.media-server.com/register/BI1059030b794549a5a265dac1ee0542eb

To watch the live webcast, please register in advance using the link below.

Webcast registration:

https://edge.media-server.com/mmc/p/y45rvzpj

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:

Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, UK
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming Group to report 1Q25 results_EN_24APR25

FAQ

When will Pharming Group (PHARM) release Q1 2025 earnings?

Pharming Group will release Q1 2025 earnings on Thursday, May 8, 2025, covering the period ended March 31, 2025.

What time is Pharming Group's (PHARM) Q1 2025 earnings call?

The earnings call is scheduled for 13:30 CEST/07:30 EDT on May 8, 2025.

How can investors participate in Pharming Group's Q1 2025 earnings call?

Investors must register in advance through the provided link to receive dial-in information and a unique PIN for call access.

Will Pharming Group (PHARM) take questions during the Q1 2025 earnings call?

Yes, but questions will only be taken from registered dial-in attendees, not webcast viewers.